Evidence map›Paper›PMID 38694735›Full record

ArticleThe Canadian veterinary journal = La revue veterinaire canadienne2024

Anticoagulant rodenticide toxicity in dogs: A retrospective study of 349 confirmed cases in Saskatchewan.

Mathieu Victor Paulin, Samantha Bray, Tanarut Laudhittirut, Jeneva Paulin, Barry Blakley, Elisabeth Snead

Open access · greenAbstract read
In one paragraph

Article in The Canadian veterinary journal = La revue veterinaire canadienne, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Retrospective evaluation of dogs presenting with hemothorax.Journal of veterinary internal medicine · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mathieu Victor PaulinDepartment of Small Animal Clinical Sciences (MV Paulin, Laudhittirut, Snead) and Department of Veterinary Biomedical Sciences (Blakley), Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4; Alpine Animal Hospital, 10 H Keenleyside Street, Winnipeg, Manitoba R2L 2B9 (Bray); VCA Central Animal Hospital, 106 103 Street East Saskatoon, Saskatchewan S7N 1Y7 (J Paulin).
Samantha BrayDepartment of Small Animal Clinical Sciences (MV Paulin, Laudhittirut, Snead) and Department of Veterinary Biomedical Sciences (Blakley), Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4; Alpine Animal Hospital, 10 H Keenleyside Street, Winnipeg, Manitoba R2L 2B9 (Bray); VCA Central Animal Hospital, 106 103 Street East Saskatoon, Saskatchewan S7N 1Y7 (J Paulin).
Tanarut LaudhittirutDepartment of Small Animal Clinical Sciences (MV Paulin, Laudhittirut, Snead) and Department of Veterinary Biomedical Sciences (Blakley), Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4; Alpine Animal Hospital, 10 H Keenleyside Street, Winnipeg, Manitoba R2L 2B9 (Bray); VCA Central Animal Hospital, 106 103 Street East Saskatoon, Saskatchewan S7N 1Y7 (J Paulin).
Jeneva PaulinDepartment of Small Animal Clinical Sciences (MV Paulin, Laudhittirut, Snead) and Department of Veterinary Biomedical Sciences (Blakley), Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4; Alpine Animal Hospital, 10 H Keenleyside Street, Winnipeg, Manitoba R2L 2B9 (Bray); VCA Central Animal Hospital, 106 103 Street East Saskatoon, Saskatchewan S7N 1Y7 (J Paulin).
Barry BlakleyDepartment of Small Animal Clinical Sciences (MV Paulin, Laudhittirut, Snead) and Department of Veterinary Biomedical Sciences (Blakley), Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4; Alpine Animal Hospital, 10 H Keenleyside Street, Winnipeg, Manitoba R2L 2B9 (Bray); VCA Central Animal Hospital, 106 103 Street East Saskatoon, Saskatchewan S7N 1Y7 (J Paulin).
Elisabeth SneadDepartment of Small Animal Clinical Sciences (MV Paulin, Laudhittirut, Snead) and Department of Veterinary Biomedical Sciences (Blakley), Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4; Alpine Animal Hospital, 10 H Keenleyside Street, Winnipeg, Manitoba R2L 2B9 (Bray); VCA Central Animal Hospital, 106 103 Street East Saskatoon, Saskatchewan S7N 1Y7 (J Paulin).
Saskatchewan Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the signalment and clinical, laboratory, treatment, and outcome features of dogs diagnosed with anticoagulant rodenticide (AR) intoxication in Saskatchewan. Animals: We studied 349 dogs. Procedure: Medical records from the Veterinary Medical Centre (Saskatoon, Saskatchewan) between 1999 and 2022 were reviewed. Cases were included if they met at least 1 of the following criteria: owner witnessed the dog ingesting an AR; AR was seen in the vomitus when emesis was induced; the dog had clinical signs of coagulopathy, with elevation of PT ± aPTT that normalized after vitamin K1 therapy, in the presence of appropriate clinical and paraclinical data and the absence of other causes of hypocoagulable state determined by the primary clinician. Results: Fifty-three percent of cases were seen between July and October. Most dogs (61%) came from an urban setting. Ninety-two percent of dogs ingested a 2nd-generation AR and the most frequent toxin was bromadiolone. Clinical signs were reported in 30% of AR intoxications and included lethargy (86%), dyspnea (55%), and evidence of external hemorrhage (44%). The most common site of hemorrhage was the pleural space, accounting for 43% of hemorrhage sites. Consumptive thrombocytopenia was reported in 24% of dogs with evidence of AR-induced hemorrhage, with moderate (platelet count < 60 K/μL) and marked (< 30 K/μL) thrombocytopenia in 7/12 and 2/12 dogs, respectively. Blood products were administered to 84% of dogs with AR-induced hemorrhage; the most common product administered was fresh frozen plasma (56% of cases). Among dogs with AR-induced hemorrhage, those that received blood products were more likely to survive to discharge (81%) compared to those that did not (19%) ( Conclusion and clinical relevance: The pleural space was the most common site of hemorrhage. Moderate thrombocytopenia was a common finding. Eighty-six percent of dogs with AR-induced hemorrhage survived to discharge.

Indexed as

AnticoagulantsDog DiseasesRodenticides4-HydroxycoumarinsAnimalsDogsFemaleMaleRetrospective StudiesSaskatchewan4-HydroxycoumarinsAnticoagulantsbromadioloneRodenticides

Identifiers

PMID38694735
PMCPMC11017940
OpenAlexW4396658425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.